Nagai, Taylor Hanta
Hartigan, Chrissy
Mizoguchi, Taiji
Yu, Haojie http://orcid.org/0000-0002-0559-0252
Deik, Amy http://orcid.org/0000-0002-9687-0953
Bullock, Kevin
Wang, Yanyan
Cromley, Debra
Schenone, Monica http://orcid.org/0000-0002-6456-8768
Cowan, Chad A.
Rader, Daniel J.
Clish, Clary B. http://orcid.org/0000-0001-8259-9245
Carr, Steven A.
Xu, Yu-Xin http://orcid.org/0000-0002-0200-4633
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (R33HL120781)
American Heart Association (11SDG7670007)
Article History
Received: 25 May 2023
Accepted: 4 December 2023
First Online: 21 December 2023
Competing interests
: The authors declare the following competing interests: D.J.R. serves on scientific advisory boards for Alnylam, Novartis, Pfizer, and Verve. C.A.C. is a founder and Chief Scientific Officer of Sana Biotechnology. The other authors declare no competing interests.